Exploring Valeda light therapy for AMD скачать в хорошем качестве

Exploring Valeda light therapy for AMD

For this My Macular and Me webinar we delve into the science behind Valeda light therapy for treating age-related macular degeneration (AMD). In this session, we were joined by Professor Tim Jackson, consultant ophthalmic surgeon from King’s College Hospital, to explore the science behind the Valeda photobiomodulation technique. The therapy uses three wavelengths of light to stimulate the layer of cells in the back of the eye called the retinal pigment epithelium (RPE), to keep them healthy for longer. Professor Jackson also discusses the data from the LIGHTSITE III clinical trial in more detail. The small study on 100 participants, with early and intermediate dry AMD, aimed to assess the impact of the therapy on visual outcomes and early changes to the back to the eye, as well as the development of late-stage dry AMD, known as geographic atrophy (GA).